As part of a Transatlantic Network of Excellence, the research group led by CRCmember Stefanie Schreiber has successfully secured a grant of eight million euros over five years from the Leducq Foundation for Cardiovascular Research.
In early 2027, UMMD will thus become a founding member of the “Transatlantic Network of Excellence.”
An international network of renowned institutions, including Harvard Medical School, Boston University, and other European and U.S. partners, will then conduct research on cerebral amyloid angiopathy (CAA).